The United Kingdom National Registry for Myotonic Dystrophy

Abroad (travel likely)Recruiting

Conditions

Myotonic Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

John Walton Muscular Dystrophy Research Centre, Newcastle upon Tyne, United Kingdom
Contact: Study coordinator (Registry Project Manager and Curator) · myotonicdystrophyregistry@newcastle.ac.uk · 0191 2418640
Contact: Principal Investigator (Chiara Marini-Bettolo, MD, PhD)

Study leads

Chiara Marini-Bettolo, MD, PhD
Principal Investigator
John Walton Muscular Dystrophy Research Centre

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Spanish National Registry for Myotonic Dystrophy Type 1

Myotonic Dystrophy 1 · DM1 · Myotonic Dystrophy Type 1

Abroad (travel likely)Recruiting

Multiple Locations, Spain · Multiple Locations, Spain

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1 (DM1) · DM1 · Myotonic Dystrophy

Abroad (travel likely)RecruitingPHASE3

La Jolla, United States · Atlanta, United States

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

DM1 · Myotonic Dystrophy · Myotonic Dystrophy 1

Abroad (travel likely)Recruiting

Richmond, United States

Personalized Training for People With Rare Neuromuscular Disorders

Neuromuscular Diseases (NMD) · Charcot Marie Tooth Disease (CMT) · Facioscapulohumeral Muscular Dystrophy

Abroad (travel likely)Recruiting

Bergen, Norway · Molde, Norway